Bloodborne infections among student voluntary blood donors in Mansoura University, Egypt

Eastern Mediterranean Health Journal

Volumn 12, Issue 6, 2006, Pages 742-748

  El Gilany, A H ^a   El Fedawy, S ^b  

^a MANSOURA UNIVERSITY   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CONTROLLED STUDY; EGYPT; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NONHUMAN; PREVALENCE; RETROSPECTIVE STUDY; SEROLOGY; SEX DIFFERENCE; SYPHILIS; UNIVERSITY STUDENT; URBAN RURAL DIFFERENCE; VIRUS STRAIN; VOLUNTEER;

ADOLESCENT; ADULT; BLOOD DONORS; BLOOD GROUP ANTIGENS; BLOOD-BORNE PATHOGENS; EGYPT; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HIV-2; HUMAN EXPERIMENTATION; HUMANS; MALE; POPULATION SURVEILLANCE; RESIDENCE CHARACTERISTICS; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; SEX DISTRIBUTION; STUDENTS; SYPHILIS; UNIVERSITIES;

EID: 33847618725     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Leikola J. Achieving self-sufficiency in blood across Europe. British medical journal, 1998, 316(7130):489-90.
2. Eastlund T. Monetary blood donation incentives and the risk of transfusion-transmitted infection. Transfusion, 1998, 38(9):874-82.
3. Sloan EM, Pitt E, Klein HG. Safety of the blood supply. Journal of the American Medical Association, 1995, 274(17): 1368-73.
4. El-Hazmi MM. Prevalence of HBV, HCV, HIV-1,2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia. Saudi medical journal, 2004, 25(1):26-33.
5. Chin J. Acquired immunodeficiency syndrome. In: Chin J, ed. Control of communicable disease manual. Washington DC, American Public Health Association, 2000:1-9.
6. Darwish MA et al. Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. American journal of tropical medicine and hygiene, 1993, 49(4):440-7.
7. Ankara-Badu GA et al. Demographic characteristics of seropositive donors in Al-Khober. Annals of Saudi medicine, 2001, 21(1,2):113-6.
8. Al-Bahrani A, Panhotra BR. Prevalence of HBsAg and anti-HCV antibodies in blood donors of the Al-Hasa region of Saudi Arabia. Annals of Saudi medicine, 2001, 21(3,4):234-238.
9. Haidar NA. Prevalence of hepatitis B and hepatitis C in blood donors and high risk groups in Hajjah, Yemen Republic. Saudi medical journal, 2002, 23(9):1090-4.
10. MacDonald M, Crofts N, Kaldor J. Transmission of hepatitis C virus: rates, routes and cofactors. Epidemiological reviews, 1996, 18(2):137-48.
11. Sherif MM et al. Incidence of hepatitis C virus infection among patients with chronic schistosomiasis. Paper presented at the 7th International Conference of the Egyptian Society of Medical Microbiology, Cairo, 10-11 March 1999.
12. El-Khanany HFM. Some epidemiological aspects of HCV antibodies among certain groups in Mansoura [thesis]. Mansoura, Egypt, Mansoura University, 1996.
13. Attia MA et al. Diverse patterns of recognition of hepatitis C virus core and nonstructural antigens by antibodies present in Egyptian cancer patients and blood donors. Journal of clinical microbiology, 1996, 34(11):2665-9.
14. Mehdi S, Pophali A, Abdul Rahim KA. Prevalence of hepatitis B and C among blood donors. Saudi medical journal, 2000, 21(10):942-4.
15. Daw MA et al. Prevalence of hepatitis C virus antibodies among different populations of relative and attributable risk. Saudi medical journal, 2002, 23(11):1356-60.
16. Vardas E et al. Prevalence of hepatitis C virus antibodies and genotyping in asymptomatic first line blood donors in Namibia. Bulletin of the World Health Organization, 1994, 77(12):965-72.
17. Alter MJ. Epidemiology of hepatitis C. Hepatology, 1997, 26(suppl. 1):62S-5S.
18. McQuillan GM et al. A population based serologic study of hepatitis C virus infection in the United States. In: Rizzetto M et al., eds. Viral hepatitis and liver disease. Turin, Italy, Edizioni Minerva Medica, 1997:267-70.
19. El-Sayed NM et al. Seroprevalence survey of Egyptian tourism workers for hepatitis B virus, hepatitis C virus, human immunodeficiency virus and Treponema pallidum infections: association of hepatitis C virus infections with specific regions of Egypt. American journal of tropical medicine and hygiene, 1996, 55(2):179-84.
20. Rizk MS et al. Epidemiology of hepatitis C virus in an Egyptian village. Journal of environmental sciences 2001, 22:103-24.
21. Farghaly AG, Barakat RM. Prevalence, impact and risk factors of hepatitis C infection. Journal of the Egyptian Public Health Association, 1993, 68:63-79.
22. Abdel-Aziz F et al. Hepatitis C virus infection in a community in the Nile Delta: population description and HCV prevalence. Hepatology, 2000, 32(1):111-5.
23. Nakashima K et al. Intrafamilial transmission of hepatitis C virus among the population of an endemic area of Japan. Journal of the American Medical Association, 1995, 274(18):1459-61.
24. Osella AR et al. Epidemiology of hepatitis C virus infection in an area of Southern Italy. Journal of hepatology, 1997, 27(1):30-5.
25. Bonkovsky HL, Mehta S. Hepatitis C: a review and update. Journal of the American Academy of Dermatology, 2001, 44(2):159-82.
26. Al-Omar A, El-Zuebi F. Disease markers in blood donors at King Fahad Hospital, Al-Baha. Annals of Saudi medicine, 1996, 16(1):37-41.
27. Akhter J et al. Use of nucleic acid testing for blood donor screening of human immunodeficiency virus and hepatitis C virus in the Saudi population. Saudi medical journal, 2001, 22(12):1073-5.
28. Country profile, HIV/AIDS, Egypt. Cairo, US Agency for International Development, Bureau for Global Health, 2004 (http://pdf.usaid.gov/ pdf_docs/PNADA672.pdf, accessed 10 April, 2005).
29. Moore A et al. Estimated risk of HIV transmission by blood transfusion in Kenya. Lancet, 2001, 358(9282):657-60.
30. Sentjens R et al. Prevalence and risk factors of HIV infection in blood donors and various population subgroups in Ethiopia. Epidemiology and infection, 2002, 128(2):221-8.
31. Luyendijk J. Egypt doesn't have AIDS, so it doesn't need AIDS education. Sexual health exchange, 2001, 2:10.
32. Epidemiological fact sheets on HIV/AIDS and sexually transmitted infections, 2002 update: Egypt. Geneva, Joint United Nations Programme on HIV/AIDS/United Nations Children's Fund/World Health Organization, 2002.
33. Initiative for HIV voluntary counselling and testing. Cairo, Ministry of Health and Population, 2003.
34. El-Sayed NM et al. Epidemic transmission of human immunodeficiency virus in renal dialysis in Egypt. Journal of infectious diseases, 2000, 181(1):91-7.